Fulgent Genetics Inc. (FLGT)
Fulgent Genetics Statistics
Share Statistics
Fulgent Genetics has 30.83M shares outstanding. The number of shares has increased by 2.69% in one year.
| Shares Outstanding | 30.83M |
| Shares Change (YoY) | 2.69% |
| Shares Change (QoQ) | 0.96% |
| Owned by Institutions (%) | 56.01% |
| Shares Floating | 19.85M |
| Failed to Deliver (FTD) Shares | 53 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 1.07M, so 3.48% of the outstanding shares have been sold short.
| Short Interest | 1.07M |
| Short % of Shares Out | 3.48% |
| Short % of Float | 5.32% |
| Short Ratio (days to cover) | 4.12 |
Valuation Ratios
The PE ratio is -13.08 and the forward PE ratio is -37.03. Fulgent Genetics's PEG ratio is 0.17.
| PE Ratio | -13.08 |
| Forward PE | -37.03 |
| PS Ratio | 1.97 |
| Forward PS | 1.4 |
| PB Ratio | 0.49 |
| P/FCF Ratio | -29 |
| PEG Ratio | 0.17 |
Enterprise Valuation
Fulgent Genetics Inc. has an Enterprise Value (EV) of 778.49M.
| EV / Earnings | -18.23 |
| EV / Sales | 2.75 |
| EV / EBITDA | -10.53 |
| EV / EBIT | -10.53 |
| EV / FCF | -40.43 |
Financial Position
The company has a current ratio of 4.85, with a Debt / Equity ratio of 0.
| Current Ratio | 4.85 |
| Quick Ratio | 4.85 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0.04 |
| Cash Flow / Debt | 51.12 |
| Interest Coverage | -434.81 |
Financial Efficiency
Return on equity (ROE) is -0.04% and return on capital (ROIC) is -5.52%.
| Return on Equity (ROE) | -0.04% |
| Return on Assets (ROA) | -0.04% |
| Return on Capital (ROIC) | -5.52% |
| Revenue Per Employee | $215,894.9 |
| Profits Per Employee | $-32,527.04 |
| Employee Count | 1,313 |
| Asset Turnover | 0.23 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -8.14M |
| Effective Tax Rate | 0.16 |
Stock Price Statistics
The stock price has increased by -22.35% in the last 52 weeks. The beta is 1.54, so Fulgent Genetics's price volatility has been higher than the market average.
| Beta | 1.54 |
| 52-Week Price Change | -22.35% |
| 50-Day Moving Average | 16.82 |
| 200-Day Moving Average | 19.74 |
| Relative Strength Index (RSI) | 48.74 |
| Average Volume (20 Days) | 415.08K |
Income Statement
In the last 12 months, Fulgent Genetics had revenue of 283.47M and earned -42.71M in profits. Earnings per share was -1.41.
| Revenue | 283.47M |
| Gross Profit | 107.22M |
| Operating Income | -73.92M |
| Net Income | -42.71M |
| EBITDA | -73.92M |
| EBIT | -73.92M |
| Earnings Per Share (EPS) | -1.41 |
Balance Sheet
The company has 55.14M in cash and 412K in debt, giving a net cash position of 54.73M.
| Cash & Cash Equivalents | 55.14M |
| Total Debt | 412K |
| Net Cash | 54.73M |
| Retained Earnings | 590.47M |
| Total Assets | 1.22B |
| Working Capital | 280.67M |
Cash Flow
In the last 12 months, operating cash flow was 21.06M and capital expenditures -40.31M, giving a free cash flow of -19.25M.
| Operating Cash Flow | 21.06M |
| Capital Expenditures | -40.31M |
| Free Cash Flow | -19.25M |
| FCF Per Share | -0.64 |
Margins
Gross margin is 37.82%, with operating and profit margins of -26.08% and -15.07%.
| Gross Margin | 37.82% |
| Operating Margin | -26.08% |
| Pretax Margin | -18.33% |
| Profit Margin | -15.07% |
| EBITDA Margin | -26.08% |
| EBIT Margin | -26.08% |
| FCF Margin | -6.79% |
Dividends & Yields
FLGT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -8.37% |
| FCF Yield | -3.71% |
Analyst Forecast
The average price target for FLGT is $16, which is -5% lower than the current price. The consensus rating is "Hold".
| Price Target | $16 |
| Price Target Difference | -5% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
Scores
| Altman Z-Score | 4.46 |
| Piotroski F-Score | 5 |